Literature DB >> 6439124

Neurofibromatosis and hypertelorism.

W Westerhof, J W Delleman, E Wolters, P Dijkstra.   

Abstract

Hypertelorism was observed in eight of 34 patients with neurofibromatosis. This diagnosis was made by measuring the intercanthal distance and calculating the interpupillary distance from it. The bones of the base of the skull and of the face are mesenchymal structures of neural crest origin. Skull dysplasias, in which hypertelorism can be included, fit well into the neurocristopathy concept of neurofibromatosis. Hypertelorism seems to herald a severe expression of neurofibromatosis, eg, with brain involvement, and would therefore be an indication for doing a computed tomographic scan. The high prevalence of hypertelorism in our group of patients (24%) makes its direct association with neurofibromatosis highly feasible. Its ease of clinical recognition and its presence at birth would make it a valuable early diagnostic criterion.

Entities:  

Mesh:

Year:  1984        PMID: 6439124

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the "NF1 facies".

Authors:  Winnie Cung; Laura A Freedman; Nicholas E Khan; Elaine Romberg; Pamela J Gardner; Carol W Bassim; Andrea M Baldwin; Brigitte C Widemann; Douglas R Stewart
Journal:  Eur J Med Genet       Date:  2015-09-08       Impact factor: 2.708

2.  Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome.

Authors:  C J van Asperen; W C Overweg-Plandsoen; M H Cnossen; D A van Tijn; R C Hennekam
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

3.  Bony orbital morphology in neurofibromatosis type 1 (NF1).

Authors:  S C Kaste; E K Pivnick
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

4.  Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

Authors:  V M Park; E K Pivnick
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

5.  Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome?

Authors:  H J Stern; H M Saal; J S Lee; P R Fain; D E Goldgar; K N Rosenbaum; D F Barker
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.